Grant awarded towards eye disease research

Article

Fight for Sight, a charity funding the research for the treatment of blindness and eye disease, has contributed grants totalling £697 350 to 7 recipients

Fight for Sight, a charity funding the research for the treatment of blindness and eye disease, has contributed grants totalling £697 350 to 7 recipients.

Research into treatments for age-related macular degeneration (AMD), glaucoma, diabetic eye disease, amblyopia, congenital cataract and keratoconus will all be provided with grants from Fight for Sight.

One of the PhD studentships has been awarded to the University of the City of London Institute of Ophthalmology and the London School of Hygiene and Tropical Medicine have received £100 000 from the charity to help them in researching the prevention of sight loss caused by trachoma. The research will study the process that causes scarring of the eyelids and gain a better understanding of trachoma.

Dr Dolores Conroy, Fight for Sight Research Officer, said: "Through these grants we are helping researchers to find ways of preventing and treating a number of serious eye conditions. We are also helping to support a new generation of vision scientists."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.